An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer
Public ClinicalTrials.gov record NCT05592483. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Multi-country Prospective Observational Study of Patients Initiating T-DXd in the First or Second Treatment Line for HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will collect real-world clinical and patient reported outcomes (PRO) and diary data from eligible patients with documented Human Epidermal Growth Factor Receptor 2 (HER2+) \[globally\] or HER2-low \[North America only\] in routine clinical practice.
Study identification
- NCT ID
- NCT05592483
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 78 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 130 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 7, 2023 (Actual)
- Primary completion
- May 29, 2024 (Actual)
- Completion
- May 29, 2024 (Actual)
- Last update posted
- Nov 7, 2024
2023 – 2024
United States locations
- U.S. sites
- 40
- U.S. states
- 23
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Mobile | Alabama | 36604 | — |
| Research Site | Chandler | Arizona | 85224 | — |
| Research Site | Little Rock | Arkansas | 72205 | — |
| Research Site | Los Angeles | California | 90064 | — |
| Research Site | Santa Rosa | California | 95403 | — |
| Research Site | Pensacola | Florida | 32503 | — |
| Research Site | Atlanta | Georgia | 30318 | — |
| Research Site | Evergreen Park | Illinois | 60805 | — |
| Research Site | Glenview | Illinois | 60026 | — |
| Research Site | Park Ridge | Illinois | 60068 | — |
| Research Site | Lexington | Kentucky | 40503 | — |
| Research Site | Louisville | Kentucky | 40202 | — |
| Research Site | Annapolis | Maryland | 21401 | — |
| Research Site | Boston | Massachusetts | 02111 | — |
| Research Site | Southfield | Michigan | 48075 | — |
| Research Site | Saint Paul | Minnesota | 55102-2389 | — |
| Research Site | Kansas City | Missouri | 64111 | — |
| Research Site | Camden | New Jersey | 08103 | — |
| Research Site | Florham Park | New Jersey | 07932 | — |
| Research Site | Jamaica | New York | 11432 | — |
| Research Site | Lake Success | New York | 11042 | — |
| Research Site | Eugene | Oregon | 97401 | — |
| Research Site | York | Pennsylvania | 17403 | — |
| Research Site | Greenville | South Carolina | 29605 | — |
| Research Site | Germantown | Tennessee | 38138-1762 | — |
| Research Site | Knoxville | Tennessee | 37916 | — |
| Research Site | Memphis | Tennessee | 38120 | — |
| Research Site | Nashville | Tennessee | 37236 | — |
| Research Site | Dallas | Texas | 75230-6899 | — |
| Research Site | Dallas | Texas | 75246 | — |
| Research Site | El Paso | Texas | 79902 | — |
| Research Site | Fort Worth | Texas | 76104 | — |
| Research Site | McAllen | Texas | 78503 | — |
| Research Site | McKinney | Texas | 75071 | — |
| Research Site | San Antonio | Texas | 78229-3900 | — |
| Research Site | Tyler | Texas | 75702 | — |
| Research Site | Portsmouth | Virginia | 23708 | — |
| Research Site | Roanoke | Virginia | 24014 | — |
| Research Site | Everett | Washington | 98201 | — |
| Research Site | Milwaukee | Wisconsin | 53215-3692 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 85 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05592483, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 7, 2024 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05592483 live on ClinicalTrials.gov.